161 related articles for article (PubMed ID: 32748408)
1. A Qualitative Study to Assess the Content Validity of the 24-Hour Migraine Quality of Life Questionnaire in Patients with Migraine.
Speck RM; Collins EM; Lombard L; Ayer DW
Headache; 2020 Oct; 60(9):1982-1994. PubMed ID: 32748408
[TBL] [Abstract][Full Text] [Related]
2. Content validity of the Migraine-Specific Quality of Life Questionnaire version 2.1 electronic patient-reported outcome.
Speck RM; Shalhoub H; Ayer DW; Ford JH; Wyrwich KW; Bush EN
J Patient Rep Outcomes; 2019 Jul; 3(1):39. PubMed ID: 31297622
[TBL] [Abstract][Full Text] [Related]
3. Psychometric validation and meaningful within-patient change of the Migraine-Specific Quality of Life questionnaire version 2.1 electronic patient-reported outcome in patients with episodic and chronic migraine.
Speck RM; Yu R; Ford JH; Ayer DW; Bhandari R; Wyrwich KW
Headache; 2021 Mar; 61(3):511-526. PubMed ID: 33481276
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a novel patient-reported outcome measure in people with episodic migraine and chronic migraine: The Activity Impairment in Migraine Diary.
Lipton RB; Gandhi P; Stokes J; Cala ML; Evans CJ; Knoble N; Gelhorn HL; Revicki D; Viswanathan HN; Dodick DW
Headache; 2022 Jan; 62(1):89-105. PubMed ID: 34962305
[TBL] [Abstract][Full Text] [Related]
5. Psychometric Validation of the Role Function Restrictive Domain of the Migraine Specific Quality-of-Life Questionnaire Version 2.1 Electronic Patient-Reported Outcome in Patients With Episodic and Chronic Migraine.
Speck RM; Shalhoub H; Wyrwich KW; Yu R; Ayer DW; Ford J; Bush EN; Lipton RB
Headache; 2019 May; 59(5):756-774. PubMed ID: 30861580
[TBL] [Abstract][Full Text] [Related]
6. Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT®) questionnaire: a new patient-reported outcome instrument for PAH.
McCollister D; Shaffer S; Badesch DB; Filusch A; Hunsche E; Schüler R; Wiklund I; Peacock A;
Respir Res; 2016 Jun; 17(1):72. PubMed ID: 27301413
[TBL] [Abstract][Full Text] [Related]
7. Development and exploration of the content validity of a patient-reported outcome measure to evaluate the impact of migraine- the migraine physical function impact diary (MPFID).
Hareendran A; Mannix S; Skalicky A; Bayliss M; Blumenfeld A; Buse DC; Desai PR; Ortmeier BG; Sapra S
Health Qual Life Outcomes; 2017 Nov; 15(1):224. PubMed ID: 29149901
[TBL] [Abstract][Full Text] [Related]
8. Content validity and electronic PRO (ePRO) usability of the Lung Cancer Symptom Scale-Mesothelioma (LCSS-Meso) in mesothelioma patients.
Gelhorn HL; Skalicky AM; Balantac Z; Eremenco S; Cimms T; Halling K; Hollen PJ; Gralla RJ; Mahoney MC; Sexton C
Support Care Cancer; 2018 Jul; 26(7):2229-2238. PubMed ID: 29392480
[TBL] [Abstract][Full Text] [Related]
9. Content validity and ePRO usability of the BPI-sf and "worst pain" item with pleural and peritoneal mesothelioma.
Gelhorn HL; Eremenco S; Skalicky AM; Balantac Z; Cimms T; Halling K; Sexton C
J Patient Rep Outcomes; 2017; 2(1):16. PubMed ID: 29749970
[TBL] [Abstract][Full Text] [Related]
10. Content Validity of HIT-6 as a Measure of Headache Impact in People With Migraine: A Narrative Review.
Houts CR; Wirth RJ; McGinley JS; Gwaltney C; Kassel E; Snapinn S; Cady R
Headache; 2020 Jan; 60(1):28-39. PubMed ID: 31811654
[TBL] [Abstract][Full Text] [Related]
11. Electronic Patient-Reported Outcomes in Hidradenitis Suppurativa: Content Validity and Usability of the Electronic Hidradenitis Suppurativa Symptom Daily Diary, Hidradenitis Suppurativa Symptom Questionnaire, and Hidradenitis Suppurativa Quality of Life Questionnaire.
Ingram JR; Ciaravino V; Rolleri R; Pansar I; Dias-Barbosa C; Kirby JS
Dermatology; 2024; 240(1):65-76. PubMed ID: 37820596
[TBL] [Abstract][Full Text] [Related]
12. Development of a New Tool for Evaluating the Benefit of Preventive Treatments for Migraine on Functional Outcomes - The Migraine Functional Impact Questionnaire (MFIQ).
Hareendran A; Skalicky A; Mannix S; Lavoie S; Desai P; Bayliss M; Thach AV; Mikol DD; Buse DC
Headache; 2018 Nov; 58(10):1612-1628. PubMed ID: 30374958
[TBL] [Abstract][Full Text] [Related]
13. Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report.
Coons SJ; Gwaltney CJ; Hays RD; Lundy JJ; Sloan JA; Revicki DA; Lenderking WR; Cella D; Basch E;
Value Health; 2009 Jun; 12(4):419-29. PubMed ID: 19900250
[TBL] [Abstract][Full Text] [Related]
14. Development and usability testing of an electronic patient-reported outcome (ePRO) solution for patients with inflammatory diseases in an Advanced Therapy Medicinal Product (ATMP) basket trial.
McMullan C; Retzer A; Hughes SE; Aiyegbusi OL; Bathurst C; Boyd A; Coleman J; Davies EH; Denniston AK; Dunster H; Frost C; Harding R; Hunn A; Kyte D; Malpass R; McNamara G; Mitchell S; Mittal S; Newsome PN; Price G; Rowe A; van Reil W; Walker A; Wilson R; Calvert M
J Patient Rep Outcomes; 2023 Oct; 7(1):98. PubMed ID: 37812323
[TBL] [Abstract][Full Text] [Related]
15. Patient-reported experiences with migraine-related cognitive symptoms: Results of the MiCOAS qualitative study.
Gerstein MT; Wirth RJ; Uzumcu AA; Houts CR; McGinley JS; Buse DC; McCarrier KP; Cooke A; Touba NM; Nishida TK; Goadsby PJ; Dodick DW; Lipton RB
Headache; 2023 Mar; 63(3):441-454. PubMed ID: 36905166
[TBL] [Abstract][Full Text] [Related]
16. Development of a patient-reported outcome measure for psychotherapeutic interventions in people with seizures: A mixed methods study.
Michaelis R; Meyer S; Reuber M; Schöne C
Epilepsy Behav; 2019 Oct; 99():106464. PubMed ID: 31421518
[TBL] [Abstract][Full Text] [Related]
17. Development of a questionnaire to assess the impact of chronic low back pain for use in regulated clinical trials.
Stokes J; Evans CJ; Pompilus F; Shields AL; Summers KH
Patient; 2013; 6(4):291-305. PubMed ID: 24062234
[TBL] [Abstract][Full Text] [Related]
18. Qualitative evaluation of the St George's Respiratory Questionnaire in patients with severe asthma.
Nelsen LM; Kimel M; Murray LT; Ortega H; Cockle SM; Yancey SW; Brusselle G; Albers FC; Jones PW
Respir Med; 2017 May; 126():32-38. PubMed ID: 28427547
[TBL] [Abstract][Full Text] [Related]
19. Development and content validity of a hemodialysis symptom patient-reported outcome measure.
Flythe JE; Dorough A; Narendra JH; Wingard RL; Dalrymple LS; DeWalt DA
Qual Life Res; 2019 Jan; 28(1):253-265. PubMed ID: 30229532
[TBL] [Abstract][Full Text] [Related]
20. The Vulvodynia Experience Questionnaire: Qualitative Development of a New Patient-Reported Outcome Measure for Vulvodynia.
Goldstein AT; Diez PMQ; Kapanadze S; Cala ML; Evans CJ; Whyte JL; Christoph A
J Sex Med; 2020 Oct; 17(10):2055-2066. PubMed ID: 32900670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
